Interpreting the language of histone and DNA modifications

Biochimica et Biophysica Acta - Gene Regulatory Mechanisms

Volumn 1839, Issue 8, 2014, Pages 627-643

  Rothbart, Scott B ^a,b   Strahl, Brian ^a,b  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Chromatin; DNA methylation; Epigenetic; Histone; Histone code; Post translational modification

Indexed keywords

DINUCLEOTIDE; DNA; HISTONE;

CHROMATIN; CPG ISLAND; DNA METHYLATION; DNA MODIFICATION; DNA PACKAGING; HISTONE CODE; HISTONE MODIFICATION; HUMAN; LANGUAGE; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW;

EUKARYOTA;

CHROMATIN; DNA METHYLATION; EPIGENETIC; HISTONE; HISTONE CODE; POST-TRANSLATIONAL MODIFICATION;

ACETYLATION; ANIMALS; CHROMATIN; DNA; DNA METHYLATION; EPIGENESIS, GENETIC; HISTONES; HUMANS; PROTEIN PROCESSING, POST-TRANSLATIONAL; SIGNAL TRANSDUCTION; SUMOYLATION; TRANSCRIPTION, GENETIC; UBIQUITINATION;

EID: 84904541089     PISSN: 18749399     EISSN: 18764320     Source Type: Journal    
DOI: 10.1016/j.bbagrm.2014.03.001     Document Type: Review

References (232)

1. Kornberg R.D., Lorch Y. Twenty-five years of the nucleosome, fundamental particle of the eukaryote chromosome. Cell 1999, 98:285-294.
2. van Holde K.E. Chromatin 1989, Springer-Verlag, New York.
3. Li G., Reinberg D. Chromatin higher-order structures and gene regulation. Curr. Opin. Genet. Dev. 2011, 21:175-186.
4. Luger K., Hansen J.C. Nucleosome and chromatin fiber dynamics. Curr. Opin. Struct. Biol. 2005, 15:188-196.
5. Zhou V.W., Goren A., Bernstein B.E. Charting histone modifications and the functional organization of mammalian genomes. Nat. Rev. Genet. 2011, 12:7-18.
6. Harshman S.W., Young N.L., Parthun M.R., Freitas M.A. H1 histones: current perspectives and challenges. Nucleic Acids Res. 2013, 41:9593-9609.
7. Talbert P.B., Henikoff S. Histone variants-ancient wrap artists of the epigenome. Nat. Rev. Mol. Cell Biol. 2010, 11:264-275.
8. Narlikar G.J., Sundaramoorthy R., Owen-Hughes T. Mechanisms and functions of ATP-dependent chromatin-remodeling enzymes. Cell 2013, 154:490-503.
9. Avvakumov N., Nourani A., Cote J. Histone chaperones: modulators of chromatin marks. Mol. Cell 2011, 41:502-514.
10. Burgess R.J., Zhang Z. Histone chaperones in nucleosome assembly and human disease. Nat. Struct. Mol. Biol. 2013, 20:14-22.
11. Bannister A.J., Kouzarides T. Regulation of chromatin by histone modifications. Cell Res. 2011, 21:381-395.
12. Greer E.L., Shi Y. Histone methylation: a dynamic mark in health, disease and inheritance. Nat. Rev. Genet. 2012, 13:343-357.
13. Klose R.J., Bird A.P. Genomic DNA methylation: the mark and its mediators. Trends Biochem. Sci. 2006, 31:89-97.
14. Kohli R.M., Zhang Y. TET enzymes, TDG and the dynamics of DNA demethylation. Nature 2013, 502:472-479.
15. Kouzarides T. Chromatin modifications and their function. Cell 2007, 128:693-705.
16. Cosgrove M.S., Boeke J.D., Wolberger C. Regulated nucleosome mobility and the histone code. Nat. Struct. Mol. Biol. 2004, 11:1037-1043.
17. Cosgrove M.S., Wolberger C. How does the histone code work?. Biochem. Cell Biol. 2005, 83:468-476.
18. Allfrey V.G., Faulkner R., Mirsky A.E. Acetylation and methylation of histones and their possible role in the regulation of RNA synthesis. Proc. Natl. Acad. Sci. U. S. A. 1964, 51:786-794.
19. Gutierrez R.M., Hnilica L.S. Tissue specificity of histone phosphorylation. Science 1967, 157:1324-1325.
20. Brownell J.E., Zhou J., Ranalli T., Kobayashi R., Edmondson D.G., Roth S.Y., Allis C.D. Tetrahymena histone acetyltransferase A: a homolog to yeast Gcn5p linking histone acetylation to gene activation. Cell 1996, 84:843-851.
21. Taunton J., Hassig C.A., Schreiber S.L. A mammalian histone deacetylase related to the yeast transcriptional regulator Rpd3p. Science 1996, 272:408-411.
22. Strahl B.D., Allis C.D. The language of covalent histone modifications. Nature 2000, 403:41-45.
23. Turner B.M. Histone acetylation and an epigenetic code. Bioessays 2000, 22:836-845.
24. Bradbury E.M. Reversible histone modifications and the chromosome cell cycle. Bioessays 1992, 14:9-16.
25. Koshland D., Strunnikov A. Mitotic chromosome condensation. Annu. Rev. Cell Dev. Biol. 1996, 12:305-333.
26. Mahadevan L.C., Willis A.C., Barratt M.J. Rapid histone H3 phosphorylation in response to growth factors, phorbol esters, okadaic acid, and protein synthesis inhibitors. Cell 1991, 65:775-783.
27. Chadee D.N., Hendzel M.J., Tylipski C.P., Allis C.D., Bazett-Jones D.P., Wright J.A., Davie J.R. Increased Ser-10 phosphorylation of histone H3 in mitogen-stimulated and oncogene-transformed mouse fibroblasts. J. Biol. Chem. 1999, 274:24914-24920.
28. De Cesare D., Jacquot S., Hanauer A., Sassone-Corsi P. Rsk-2 activity is necessary for epidermal growth factor-induced phosphorylation of CREB protein and transcription of c-fos gene. Proc. Natl. Acad. Sci. U. S. A. 1998, 95:12202-12207.
29. Shogren-Knaak M., Ishii H., Sun J.M., Pazin M.J., Davie J.R., Peterson C.L. Histone H4-K16 acetylation controls chromatin structure and protein interactions. Science 2006, 311:844-847.
30. Dhalluin C., Carlson J.E., Zeng L., He C., Aggarwal A.K., Zhou M.M. Structure and ligand of a histone acetyltransferase bromodomain. Nature 1999, 399:491-496.
31. Filippakopoulos P., Picaud S., Mangos M., Keates T., Lambert J.P., Barsyte-Lovejoy D., Felletar I., Volkmer R., Muller S., Pawson T., Gingras A.C., Arrowsmith C.H., Knapp S. Histone recognition and large-scale structural analysis of the human bromodomain family. Cell 2012, 149:214-231.
32. Jacobson R.H., Ladurner A.G., King D.S., Tjian R. Structure and function of a human TAFII250 double bromodomain module. Science 2000, 288:1422-1425.
33. Musselman C.A., Lalonde M.E., Cote J., Kutateladze T.G. Perceiving the epigenetic landscape through histone readers. Nat. Struct. Mol. Biol. 2012, 19:1218-1227.
34. Patel D.J., Wang Z. Readout of epigenetic modifications. Annu. Rev. Biochem. 2013, 82:81-118.
35. Voigt P., LeRoy G., Drury W.J., Zee B.M., Son J., Beck D.B., Young N.L., Garcia B.A., Reinberg D. Asymmetrically modified nucleosomes. Cell 2012, 151:181-193.
36. Arnaudo A.M., Garcia B.A. Proteomic characterization of novel histone post-translational modifications. Epigenetics Chromatin 2013, 6:24.
37. Spruijt C.G., Gnerlich F., Smits A.H., Pfaffeneder T., Jansen P.W., Bauer C., Munzel M., Wagner M., Muller M., Khan F., Eberl H.C., Mensinga A., Brinkman A.B., Lephikov K., Muller U., Walter J., Boelens R., van Ingen H., Leonhardt H., Carell T., Vermeulen M. Dynamic readers for 5-(hydroxy)methylcytosine and its oxidized derivatives. Cell 2013, 152:1146-1159.
38. Hake S.B., Xiao A., Allis C.D. Linking the epigenetic 'language' of covalent histone modifications to cancer. Br. J. Cancer 2004, 90:761-769.
39. Bartke T., Borgel J., DiMaggio P.A. Proteomics in epigenetics: new perspectives for cancer research. Brief. Funct. Genomics 2013, 12:205-218.
40. Garcia B.A., Pesavento J.J., Mizzen C.A., Kelleher N.L. Pervasive combinatorial modification of histone H3 in human cells. Nat. Methods 2007, 4:487-489.
41. Han Y., Garcia B.A. Combining genomic and proteomic approaches for epigenetics research. Epigenomics 2013, 5:439-452.
42. Soldi M., Cuomo A., Bremang M., Bonaldi T. Mass spectrometry-based proteomics for the analysis of chromatin structure and dynamics. Int. J. Mol. Sci. 2013, 14:5402-5431.
43. Vermeulen M., Eberl H.C., Matarese F., Marks H., Denissov S., Butter F., Lee K.K., Olsen J.V., Hyman A.A., Stunnenberg H.G., Mann M. Quantitative interaction proteomics and genome-wide profiling of epigenetic histone marks and their readers. Cell 2010, 142:967-980.
44. Zhang L., Eugeni E.E., Parthun M.R., Freitas M.A. Identification of novel histone post-translational modifications by peptide mass fingerprinting. Chromosoma 2003, 112:77-86.
45. Zhang K., Tang H., Huang L., Blankenship J.W., Jones P.R., Xiang F., Yau P.M., Burlingame A.L. Identification of acetylation and methylation sites of histone H3 from chicken erythrocytes by high-accuracy matrix-assisted laser desorption ionization-time-of-flight, matrix-assisted laser desorption ionization-postsource decay, and nanoelectrospray ionization tandem mass spectrometry. Anal. Biochem. 2002, 306:259-269.
46. Cosgrove M.S. Histone proteomics and the epigenetic regulation of nucleosome mobility. Expert Rev. Proteomics 2007, 4:465-478.
47. Cocklin R.R., Wang M. Identification of methylation and acetylation sites on mouse histone H3 using matrix-assisted laser desorption/ionization time-of-flight and nanoelectrospray ionization tandem mass spectrometry. J. Protein Chem. 2003, 22:327-334.
48. Neumann H., Hancock S.M., Buning R., Routh A., Chapman L., Somers J., Owen-Hughes T., van Noort J., Rhodes D., Chin J.W. A method for genetically installing site-specific acetylation in recombinant histones defines the effects of H3 K56 acetylation. Mol. Cell 2009, 36:153-163.
49. Manohar M., Mooney A.M., North J.A., Nakkula R.J., Picking J.W., Edon A., Fishel R., Poirier M.G., Ottesen J.J. Acetylation of histone H3 at the nucleosome dyad alters DNA-histone binding. J. Biol. Chem. 2009, 284:23312-23321.
50. North J.A., Javaid S., Ferdinand M.B., Chatterjee N., Picking J.W., Shoffner M., Nakkula R.J., Bartholomew B., Ottesen J.J., Fishel R., Poirier M.G. Phosphorylation of histone H3(T118) alters nucleosome dynamics and remodeling. Nucleic Acids Res. 2011, 39:6465-6474.
51. Simon M., North J.A., Shimko J.C., Forties R.A., Ferdinand M.B., Manohar M., Zhang M., Fishel R., Ottesen J.J., Poirier M.G. Histone fold modifications control nucleosome unwrapping and disassembly. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:12711-12716.
52. Shimko J.C., North J.A., Bruns A.N., Poirier M.G., Ottesen J.J. Preparation of fully synthetic histone H3 reveals that acetyl-lysine 56 facilitates protein binding within nucleosomes. J. Mol. Biol. 2011, 408:187-204.
53. Watanabe S., Resch M., Lilyestrom W., Clark N., Hansen J.C., Peterson C., Luger K. Structural characterization of H3K56Q nucleosomes and nucleosomal arrays. Biochim. Biophys. Acta 2010, 1799:480-486.
54. Tropberger P., Pott S., Keller C., Kamieniarz-Gdula K., Caron M., Richter F., Li G., Mittler G., Liu E.T., Buhler M., Margueron R., Schneider R. Regulation of transcription through acetylation of H3K122 on the lateral surface of the histone octamer. Cell 2013, 152:859-872.
55. Dawson M.A., Bannister A.J., Gottgens B., Foster S.D., Bartke T., Green A.R., Kouzarides T. JAK2 phosphorylates histone H3Y41 and excludes HP1alpha from chromatin. Nature 2009, 461:819-822.
56. Hathaway N.A., Bell O., Hodges C., Miller E.L., Neel D.S., Crabtree G.R. Dynamics and memory of heterochromatin in living cells. Cell 2012, 149:1447-1460.
57. Jacobs S.A., Khorasanizadeh S. Structure of HP1 chromodomain bound to a lysine 9-methylated histone H3 tail. Science 2002, 295:2080-2083.
58. Casadio F., Lu X., Pollock S.B., LeRoy G., Garcia B.A., Muir T.W., Roeder R.G., Allis C.D. H3R42me2a is a histone modification with positive transcriptional effects. Proc. Natl. Acad. Sci. U. S. A. 2013, 110:14894-14899.
59. Tan M., Luo H., Lee S., Jin F., Yang J.S., Montellier E., Buchou T., Cheng Z., Rousseaux S., Rajagopal N., Lu Z., Ye Z., Zhu Q., Wysocka J., Ye Y., Khochbin S., Ren B., Zhao Y. Identification of 67 histone marks and histone lysine crotonylation as a new type of histone modification. Cell 2011, 146:1016-1028.
60. Montellier E., Rousseaux S., Zhao Y., Khochbin S. Histone crotonylation specifically marks the haploid male germ cell gene expression program: post-meiotic male-specific gene expression. Bioessays 2012, 34:187-193.
61. Sin H.S., Barski A., Zhang F., Kartashov A.V., Nussenzweig A., Chen J., Andreassen P.R., Namekawa S.H. RNF8 regulates active epigenetic modifications and escape gene activation from inactive sex chromosomes in post-meiotic spermatids. Genes Dev. 2012, 26:2737-2748.
62. Montellier E., Boussouar F., Rousseaux S., Zhang K., Buchou T., Fenaille F., Shiota H., Debernardi A., Hery P., Curtet S., Jamshidikia M., Barral S., Holota H., Bergon A., Lopez F., Guardiola P., Pernet K., Imbert J., Petosa C., Tan M., Zhao Y., Gerard M., Khochbin S. Chromatin-to-nucleoprotamine transition is controlled by the histone H2B variant TH2B. Genes Dev. 2013, 27:1680-1692.
63. Kreppel L.K., Blomberg M.A., Hart G.W. Dynamic glycosylation of nuclear and cytosolic proteins. Cloning and characterization of a unique O-GlcNAc transferase with multiple tetratricopeptide repeats. J. Biol. Chem. 1997, 272:9308-9315.
64. Lubas W.A., Frank D.W., Krause M., Hanover J.A. O-linked GlcNAc transferase is a conserved nucleocytoplasmic protein containing tetratricopeptide repeats. J. Biol. Chem. 1997, 272:9316-9324.
65. Gao Y., Wells L., Comer F.I., Parker G.J., Hart G.W. Dynamic O-glycosylation of nuclear and cytosolic proteins: cloning and characterization of a neutral, cytosolic beta-N-acetylglucosaminidase from human brain. J. Biol. Chem. 2001, 276:9838-9845.
66. Comtesse N., Maldener E., Meese E. Identification of a nuclear variant of MGEA5, a cytoplasmic hyaluronidase and a beta-N-acetylglucosaminidase. Biochem. Biophys. Res. Commun. 2001, 283:634-640.
67. Bond M.R., Hanover J.A. O-GlcNAc cycling: a link between metabolism and chronic disease. Annu. Rev. Nutr. 2013, 33:205-229.
68. Hanover J.A., Krause M.W., Love D.C. Bittersweet memories: linking metabolism to epigenetics through O-GlcNAcylation. Nat. Rev. Mol. Cell Biol. 2012, 13:312-321.
69. Love D.C., Ghosh S., Mondoux M.A., Fukushige T., Wang P., Wilson M.A., Iser W.B., Wolkow C.A., Krause M.W., Hanover J.A. Dynamic O-GlcNAc cycling at promoters of Caenorhabditis elegans genes regulating longevity, stress, and immunity. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:7413-7418.
70. Gambetta M.C., Oktaba K., Muller J. Essential role of the glycosyltransferase sxc/Ogt in polycomb repression. Science 2009, 325:93-96.
71. Sinclair D.A., Syrzycka M., Macauley M.S., Rastgardani T., Komljenovic I., Vocadlo D.J., Brock H.W., Honda B.M. Drosophila O-GlcNAc transferase (OGT) is encoded by the Polycomb group (PcG) gene, super sex combs (sxc). Proc. Natl. Acad. Sci. U. S. A. 2009, 106:13427-13432.
72. Kelly W.G., Dahmus M.E., Hart G.W. RNA polymerase II is a glycoprotein. Modification of the COOH-terminal domain by O-GlcNAc. J. Biol. Chem. 1993, 268:10416-10424.
73. Comer F.I., Hart G.W. Reciprocity between O-GlcNAc and O-phosphate on the carboxyl terminal domain of RNA polymerase II. Biochemistry 2001, 40:7845-7852.
74. Fujiki R., Chikanishi T., Hashiba W., Ito H., Takada I., Roeder R.G., Kitagawa H., Kato S. GlcNAcylation of a histone methyltransferase in retinoic-acid-induced granulopoiesis. Nature 2009, 459:455-459.
75. Zhang S., Roche K., Nasheuer H.P., Lowndes N.F. Modification of histones by sugar beta-N-acetylglucosamine (GlcNAc) occurs on multiple residues, including histone H3 serine 10, and is cell cycle-regulated. J. Biol. Chem. 2011, 286:37483-37495.
76. Fujiki R., Hashiba W., Sekine H., Yokoyama A., Chikanishi T., Ito S., Imai Y., Kim J., He H.H., Igarashi K., Kanno J., Ohtake F., Kitagawa H., Roeder R.G., Brown M., Kato S. GlcNAcylation of histone H2B facilitates its monoubiquitination. Nature 2011, 480:557-560.
77. Chen Q., Chen Y., Bian C., Fujiki R., Yu X. TET2 promotes histone O-GlcNAcylation during gene transcription. Nature 2013, 493:561-564.
78. Chen Y., Sprung R., Tang Y., Ball H., Sangras B., Kim S.C., Falck J.R., Peng J., Gu W., Zhao Y. Lysine propionylation and butyrylation are novel post-translational modifications in histones. Mol. Cell. Proteomics 2007, 6:812-819.
79. Zhang K., Chen Y., Zhang Z., Zhao Y. Identification and verification of lysine propionylation and butyrylation in yeast core histones using PTMap software. J. Proteome Res. 2009, 8:900-906.
80. Kaelin W.G., McKnight S.L. Influence of metabolism on epigenetics and disease. Cell 2013, 153:56-69.
81. Gut P., Verdin E. The nexus of chromatin regulation and intermediary metabolism. Nature 2013, 502:489-498.
82. Vollmuth F., Geyer M. Interaction of propionylated and butyrylated histone H3 lysine marks with Brd4 bromodomains. Angew. Chem. Int. Ed. Engl. 2010, 49:6768-6772.
83. Young N.L., DiMaggio P.A., Plazas-Mayorca M.D., Baliban R.C., Floudas C.A., Garcia B.A. High throughput characterization of combinatorial histone codes. Mol. Cell. Proteomics 2009, 8:2266-2284.
84. Tweedie-Cullen R.Y., Brunner A.M., Grossmann J., Mohanna S., Sichau D., Nanni P., Panse C., Mansuy I.M. Identification of combinatorial patterns of post-translational modifications on individual histones in the mouse brain. PLoS One 2012, 7:e36980.
85. Taverna S.D., Ueberheide B.M., Liu Y., Tackett A.J., Diaz R.L., Shabanowitz J., Chait B.T., Hunt D.F., Allis C.D. Long-distance combinatorial linkage between methylation and acetylation on histone H3 N termini. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:2086-2091.
86. Hazzalin C.A., Mahadevan L.C. Dynamic acetylation of all lysine 4-methylated histone H3 in the mouse nucleus: analysis at c-fos and c-jun. PLoS Biol. 2005, 3:e393.
87. Bock I., Kudithipudi S., Tamas R., Kungulovski G., Dhayalan A., Jeltsch A. Application of Celluspots peptide arrays for the analysis of the binding specificity of epigenetic reading domains to modified histone tails. BMC Biochem. 2011, 12:48.
88. Bua D.J., Kuo A.J., Cheung P., Liu C.L., Migliori V., Espejo A., Casadio F., Bassi C., Amati B., Bedford M.T., Guccione E., Gozani O. Epigenome microarray platform for proteome-wide dissection of chromatin-signaling networks. PLoS One 2009, 4:e6789.
89. Fuchs S.M., Krajewski K., Baker R.W., Miller V.L., Strahl B.D. Influence of combinatorial histone modifications on antibody and effector protein recognition. Curr. Biol. 2011, 21:53-58.
90. Nady N., Min J., Kareta M.S., Chedin F., Arrowsmith C.H. A SPOT on the chromatin landscape? Histone peptide arrays as a tool for epigenetic research. Trends Biochem. Sci. 2008, 33:305-313.
91. Rathert P., Dhayalan A., Murakami M., Zhang X., Tamas R., Jurkowska R., Komatsu Y., Shinkai Y., Cheng X., Jeltsch A. Protein lysine methyltransferase G9a acts on non-histone targets. Nat. Chem. Biol. 2008, 4:344-346.
92. Rothbart S.B., Krajewski K., Strahl B.D., Fuchs S.M. Peptide microarrays to interrogate the "histone code". Methods Enzymol. 2012, 512:107-135.
93. Fuchs S.M., Strahl B.D. Antibody recognition of histone post-translational modifications: emerging issues and future prospects. Epigenomics 2011, 3:247-249.
94. Di Croce L., Helin K. Transcriptional regulation by Polycomb group proteins. Nat. Struct. Mol. Biol. 2013, 20:1147-1155.
95. Beck D.B., Oda H., Shen S.S., Reinberg D. PR-Set7 and H4K20me1: at the crossroads of genome integrity, cell cycle, chromosome condensation, and transcription. Genes Dev. 2012, 26:325-337.
96. Voigt P., Tee W.W., Reinberg D. A double take on bivalent promoters. Genes Dev. 2013, 27:1318-1338.
97. Schmitges F.W., Prusty A.B., Faty M., Stutzer A., Lingaraju G.M., Aiwazian J., Sack R., Hess D., Li L., Zhou S., Bunker R.D., Wirth U., Bouwmeester T., Bauer A., Ly-Hartig N., Zhao K., Chan H., Gu J., Gut H., Fischle W., Muller J., Thoma N.H. Histone methylation by PRC2 is inhibited by active chromatin marks. Mol. Cell 2011, 42:330-341.
98. Ruthenburg A.J., Li H., Patel D.J., Allis C.D. Multivalent engagement of chromatin modifications by linked binding modules. Nat. Rev. Mol. Cell Biol. 2007, 8:983-994.
99. Ali M., Yan K., Lalonde M.E., Degerny C., Rothbart S.B., Strahl B.D., Cote J., Yang X.J., Kutateladze T.G. Tandem PHD fingers of MORF/MOZ acetyltransferases display selectivity for acetylated histone H3 and are required for the association with chromatin. J. Mol. Biol. 2012, 424:328-338.
100. Arita K., Isogai S., Oda T., Unoki M., Sugita K., Sekiyama N., Kuwata K., Hamamoto R., Tochio H., Sato M., Ariyoshi M., Shirakawa M. Recognition of modification status on a histone H3 tail by linked histone reader modules of the epigenetic regulator UHRF1. Proc. Natl. Acad. Sci. U. S. A. 2012, 109:12950-12955.
101. Dreveny I., Deeves S.E., Fulton J., Yue B., Messmer M., Bhattacharya A., Collins H.M., Heery D.M. The double PHD finger domain of MOZ/MYST3 induces alpha-helical structure of the histone H3 tail to facilitate acetylation and methylation sampling and modification. Nucleic Acids Res. 2013, 42:822-835.
102. Eustermann S., Yang J.C., Law M.J., Amos R., Chapman L.M., Jelinska C., Garrick D., Clynes D., Gibbons R.J., Rhodes D., Higgs D.R., Neuhaus D. Combinatorial readout of histone H3 modifications specifies localization of ATRX to heterochromatin. Nat. Struct. Mol. Biol. 2011, 18:777-782.
103. Qiu Y., Liu L., Zhao C., Han C., Li F., Zhang J., Wang Y., Li G., Mei Y., Wu M., Wu J., Shi Y. Combinatorial readout of unmodified H3R2 and acetylated H3K14 by the tandem PHD finger of MOZ reveals a regulatory mechanism for HOXA9 transcription. Genes Dev. 2012, 26:1376-1391.
104. Rothbart S.B., Dickson B.M., Ong M.S., Krajewski K., Houliston S., Kireev D.B., Arrowsmith C.H., Strahl B.D. Multivalent histone engagement by the linked tandem Tudor and PHD domains of UHRF1 is required for the epigenetic inheritance of DNA methylation. Genes Dev. 2013, 27:1288-1298.
105. Tsai W.W., Wang Z., Yiu T.T., Akdemir K.C., Xia W., Winter S., Tsai C.Y., Shi X., Schwarzer D., Plunkett W., Aronow B., Gozani O., Fischle W., Hung M.C., Patel D.J., Barton M.C. TRIM24 links a non-canonical histone signature to breast cancer. Nature 2010, 468:927-932.
106. Xi Q., Wang Z., Zaromytidou A.I., Zhang X.H., Chow-Tsang L.F., Liu J.X., Kim H., Barlas A., Manova-Todorova K., Kaartinen V., Studer L., Mark W., Patel D.J., Massague J. A poised chromatin platform for TGF-beta access to master regulators. Cell 2011, 147:1511-1524.
107. Nady N., Lemak A., Walker J.R., Avvakumov G.V., Kareta M.S., Achour M., Xue S., Duan S., Allali-Hassani A., Zuo X., Wang Y.X., Bronner C., Chedin F., Arrowsmith C.H., Dhe-Paganon S. Recognition of multivalent histone states associated with heterochromatin by UHRF1 protein. J. Biol. Chem. 2011, 286:24300-24311.
108. Rajakumara E., Wang Z., Ma H., Hu L., Chen H., Lin Y., Guo R., Wu F., Li H., Lan F., Shi Y.G., Xu Y., Patel D.J., Shi Y. PHD finger recognition of unmodified histone H3R2 links UHRF1 to regulation of euchromatic gene expression. Mol. Cell 2011, 43:275-284.
109. Johnson L.M., Fisher-Adams G., Grunstein M. Identification of a non-basic domain in the histone H4 N-terminus required for repression of the yeast silent mating loci. EMBO J. 1992, 11:2201-2209.
110. Potoyan D.A., Papoian G.A. Energy landscape analyses of disordered histone tails reveal special organization of their conformational dynamics. J. Am. Chem. Soc. 2011, 133:7405-7415.
111. Feng Y., Wang J., Asher S., Hoang L., Guardiani C., Ivanov I., Zheng Y.G. Histone H4 acetylation differentially modulates arginine methylation by an in Cis mechanism. J. Biol. Chem. 2011, 286:20323-20334.
112. Musselman C.A., Ramirez J., Sims J.K., Mansfield R.E., Oliver S.S., Denu J.M., Mackay J.P., Wade P.A., Hagman J., Kutateladze T.G. Bivalent recognition of nucleosomes by the tandem PHD fingers of the CHD4 ATPase is required for CHD4-mediated repression. Proc. Natl. Acad. Sci. U. S. A. 2012, 109:787-792.
113. Oliver S.S., Musselman C.A., Srinivasan R., Svaren J.P., Kutateladze T.G., Denu J.M. Multivalent recognition of histone tails by the PHD fingers of CHD5. Biochemistry 2012, 51:6534-6544.
114. Ruthenburg A.J., Li H., Milne T.A., Dewell S., McGinty R.K., Yuen M., Ueberheide B., Dou Y., Muir T.W., Patel D.J., Allis C.D. Recognition of a mononucleosomal histone modification pattern by BPTF via multivalent interactions. Cell 2011, 145:692-706.
115. Ali M., Rincon-Arano H., Zhao W., Rothbart S.B., Tong Q., Parkhurst S.M., Strahl B.D., Deng L.W., Groudine M., Kutateladze T.G. Molecular basis for chromatin binding and regulation of MLL5. Proc. Natl. Acad. Sci. U. S. A. 2013, 110:11296-11301.
116. Gatchalian J., Futterer A., Rothbart S.B., Tong Q., Rincon-Arano H., Sanchez de Diego A., Groudine M., Strahl B.D., Martinez A.C., van Wely K.H., Kutateladze T.G. Dido3 PHD modulates cell differentiation and division. Cell Rep. 2013, 4:148-158.
117. Kinkelin K., Wozniak G.G., Rothbart S.B., Lidschreiber M., Strahl B.D., Cramer P. Structures of RNA polymerase II complexes with Bye1, a chromatin-binding PHF3/DIDO homologue. Proc. Natl. Acad. Sci. U. S. A. 2013, 110:15277-15282.
118. Rothbart S.B., Krajewski K., Nady N., Tempel W., Xue S., Badeaux A.I., Barsyte-Lovejoy D., Martinez J.Y., Bedford M.T., Fuchs S.M., Arrowsmith C.H., Strahl B.D. Association of UHRF1 with methylated H3K9 directs the maintenance of DNA methylation. Nat. Struct. Mol. Biol. 2012, 19:1155-1160.
119. Kokura K., Sun L., Bedford M.T., Fang J. Methyl-H3K9-binding protein MPP8 mediates E-cadherin gene silencing and promotes tumour cell motility and invasion. EMBO J. 2010, 29:3673-3687.
120. Escamilla-Del-Arenal M., da Rocha S.T., Spruijt C.G., Masui O., Renaud O., Smits A.H., Margueron R., Vermeulen M., Heard E. Cdyl, a new partner of the inactive X chromosome and potential reader of H3K27me3 and H3K9me2. Mol. Cell. Biol. 2013, 33:5005-5020.
121. Collins R.E., Northrop J.P., Horton J.R., Lee D.Y., Zhang X., Stallcup M.R., Cheng X. The ankyrin repeats of G9a and GLP histone methyltransferases are mono- and dimethyllysine binding modules. Nat. Struct. Mol. Biol. 2008, 15:245-250.
122. Fasting C., Schalley C.A., Weber M., Seitz O., Hecht S., Koksch B., Dernedde J., Graf C., Knapp E.W., Haag R. Multivalency as a chemical organization and action principle. Angew. Chem. Int. Ed. Engl. 2012, 51:10472-10498.
123. Fierz B., Muir T.W. Chromatin as an expansive canvas for chemical biology. Nat. Chem. Biol. 2012, 8:417-427.
124. Ptashne M. Regulation of transcription: from lambda to eukaryotes. Trends Biochem. Sci. 2005, 30:275-279.
125. Henikoff S., Furuyama T., Ahmad K. Histone variants, nucleosome assembly and epigenetic inheritance. Trends Genet. 2004, 20:320-326.
126. Bird A.P. DNA methylation and the frequency of CpG in animal DNA. Nucleic Acids Res. 1980, 8:1499-1504.
127. Watt F., Molloy P.L. Cytosine methylation prevents binding to DNA of a HeLa cell transcription factor required for optimal expression of the adenovirus major late promoter. Genes Dev. 1988, 2:1136-1143.
128. Nan X., Meehan R.R., Bird A. Dissection of the methyl-CpG binding domain from the chromosomal protein MeCP2. Nucleic Acids Res. 1993, 21:4886-4892.
129. Amir R.E., Van den Veyver I.B., Wan M., Tran C.Q., Francke U., Zoghbi H.Y. Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat. Genet. 1999, 23:185-188.
130. Guy J., Cheval H., Selfridge J., Bird A. The role of MeCP2 in the brain. Annu. Rev. Cell Dev. Biol. 2011, 27:631-652.
131. Nan X., Campoy F.J., Bird A. MeCP2 is a transcriptional repressor with abundant binding sites in genomic chromatin. Cell 1997, 88:471-481.
132. Lyst M.J., Ekiert R., Ebert D.H., Merusi C., Nowak J., Selfridge J., Guy J., Kastan N.R., Robinson N.D., de Lima Alves F., Rappsilber J., Greenberg M.E., Bird A. Rett syndrome mutations abolish the interaction of MeCP2 with the NCoR/SMRT co-repressor. Nat. Neurosci. 2013, 16:898-902.
133. Hendrich B., Bird A. Identification and characterization of a family of mammalian methyl-CpG binding proteins. Mol. Cell. Biol. 1998, 18:6538-6547.
134. Hendrich B., Guy J., Ramsahoye B., Wilson V.A., Bird A. Closely related proteins MBD2 and MBD3 play distinctive but interacting roles in mouse development. Genes Dev. 2001, 15:710-723.
135. Martin Caballero I., Hansen J., Leaford D., Pollard S., Hendrich B.D. The methyl-CpG binding proteins Mecp2, Mbd2 and Kaiso are dispensable for mouse embryogenesis, but play a redundant function in neural differentiation. PLoS One 2009, 4:e4315.
136. Hutchins A.S., Mullen A.C., Lee H.W., Sykes K.J., High F.A., Hendrich B.D., Bird A.P., Reiner S.L. Gene silencing quantitatively controls the function of a developmental trans-activator. Mol. Cell 2002, 10:81-91.
137. Zhao X., Ueba T., Christie B.R., Barkho B., McConnell M.J., Nakashima K., Lein E.S., Eadie B.D., Willhoite A.R., Muotri A.R., Summers R.G., Chun J., Lee K.F., Gage F.H. Mice lacking methyl-CpG binding protein 1 have deficits in adult neurogenesis and hippocampal function. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:6777-6782.
138. Saito M., Ishikawa F. The mCpG-binding domain of human MBD3 does not bind to mCpG but interacts with NuRD/Mi2 components HDAC1 and MTA2. J. Biol. Chem. 2002, 277:35434-35439.
139. Yildirim O., Li R., Hung J.H., Chen P.B., Dong X., Ee L.S., Weng Z., Rando O.J., Fazzio T.G. Mbd3/NURD complex regulates expression of 5-hydroxymethylcytosine marked genes in embryonic stem cells. Cell 2011, 147:1498-1510.
140. Baubec T., Ivanek R., Lienert F., Schubeler D. Methylation-dependent and -independent genomic targeting principles of the MBD protein family. Cell 2013, 153:480-492.
141. Hashimoto H., Liu Y., Upadhyay A.K., Chang Y., Howerton S.B., Vertino P.M., Zhang X., Cheng X. Recognition and potential mechanisms for replication and erasure of cytosine hydroxymethylation. Nucleic Acids Res. 2012, 40:4841-4849.
142. Prokhortchouk A., Hendrich B., Jorgensen H., Ruzov A., Wilm M., Georgiev G., Bird A., Prokhortchouk E. The p120 catenin partner Kaiso is a DNA methylation-dependent transcriptional repressor. Genes Dev. 2001, 15:1613-1618.
143. Yoon H.G., Chan D.W., Reynolds A.B., Qin J., Wong J. N-CoR mediates DNA methylation-dependent repression through a methyl CpG binding protein Kaiso. Mol. Cell 2003, 12:723-734.
144. Kim S.W., Park J.I., Spring C.M., Sater A.K., Ji H., Otchere A.A., Daniel J.M., McCrea P.D. Non-canonical Wnt signals are modulated by the Kaiso transcriptional repressor and p120-catenin. Nat. Cell Biol. 2004, 6:1212-1220.
145. Park J.I., Kim S.W., Lyons J.P., Ji H., Nguyen T.T., Cho K., Barton M.C., Deroo T., Vleminckx K., Moon R.T., McCrea P.D. Kaiso/p120-catenin and TCF/beta-catenin complexes coordinately regulate canonical Wnt gene targets. Dev. Cell 2005, 8:843-854.
146. Buck-Koehntop B.A., Stanfield R.L., Ekiert D.C., Martinez-Yamout M.A., Dyson H.J., Wilson I.A., Wright P.E. Molecular basis for recognition of methylated and specific DNA sequences by the zinc finger protein Kaiso. Proc. Natl. Acad. Sci. U. S. A. 2012, 109:15229-15234.
147. Johnson L.M., Bostick M., Zhang X., Kraft E., Henderson I., Callis J., Jacobsen S.E. The SRA methyl-cytosine-binding domain links DNA and histone methylation. Curr. Biol. 2007, 17:379-384.
148. Bronner C., Achour M., Arima Y., Chataigneau T., Saya H., Schini-Kerth V.B. The UHRF family: oncogenes that are drugable targets for cancer therapy in the near future?. Pharmacol. Ther. 2007, 115:419-434.
149. Unoki M., Nishidate T., Nakamura Y. ICBP90, an E2F-1 target, recruits HDAC1 and binds to methyl-CpG through its SRA domain. Oncogene 2004, 23:7601-7610.
150. Qian C., Li S., Jakoncic J., Zeng L., Walsh M.J., Zhou M.M. Structure and hemimethylated CpG binding of the SRA domain from human UHRF1. J. Biol. Chem. 2008, 283:34490-34494.
151. Arita K., Ariyoshi M., Tochio H., Nakamura Y., Shirakawa M. Recognition of hemi-methylated DNA by the SRA protein UHRF1 by a base-flipping mechanism. Nature 2008, 455:818-821.
152. Avvakumov G.V., Walker J.R., Xue S., Li Y., Duan S., Bronner C., Arrowsmith C.H., Dhe-Paganon S. Structural basis for recognition of hemi-methylated DNA by the SRA domain of human UHRF1. Nature 2008, 455:822-825.
153. Hashimoto H., Horton J.R., Zhang X., Bostick M., Jacobsen S.E., Cheng X. The SRA domain of UHRF1 flips 5-methylcytosine out of the DNA helix. Nature 2008, 455:826-829.
154. Klimasauskas S., Kumar S., Roberts R.J., Cheng X. HhaI methyltransferase flips its target base out of the DNA helix. Cell 1994, 76:357-369.
155. Song J., Teplova M., Ishibe-Murakami S., Patel D.J. Structure-based mechanistic insights into DNMT1-mediated maintenance DNA methylation. Science 2012, 335:709-712.
156. Holliday R., Pugh J.E. DNA modification mechanisms and gene activity during development. Science 1975, 187:226-232.
157. Razin A., Riggs A.D. DNA methylation and gene function. Science 1980, 210:604-610.
158. Achour M., Jacq X., Ronde P., Alhosin M., Charlot C., Chataigneau T., Jeanblanc M., Macaluso M., Giordano A., Hughes A.D., Schini-Kerth V.B., Bronner C. The interaction of the SRA domain of ICBP90 with a novel domain of DNMT1 is involved in the regulation of VEGF gene expression. Oncogene 2008, 27:2187-2197.
159. Bostick M., Kim J.K., Esteve P.O., Clark A., Pradhan S., Jacobsen S.E. UHRF1 plays a role in maintaining DNA methylation in mammalian cells. Science 2007, 317:1760-1764.
160. Sharif J., Muto M., Takebayashi S., Suetake I., Iwamatsu A., Endo T.A., Shinga J., Mizutani-Koseki Y., Toyoda T., Okamura K., Tajima S., Mitsuya K., Okano M., Koseki H. The SRA protein Np95 mediates epigenetic inheritance by recruiting Dnmt1 to methylated DNA. Nature 2007, 450:908-912.
161. Nishiyama A., Yamaguchi L., Sharif J., Johmura Y., Kawamura T., Nakanishi K., Shimamura S., Arita K., Kodama T., Ishikawa F., Koseki H., Nakanishi M. Uhrf1-dependent H3K23 ubiquitylation couples maintenance DNA methylation and replication. Nature 2013, 502:249-253.
162. Mittler G., Butter F., Mann M. A SILAC-based DNA protein interaction screen that identifies candidate binding proteins to functional DNA elements. Genome Res. 2009, 19:284-293.
163. Bartke T., Vermeulen M., Xhemalce B., Robson S.C., Mann M., Kouzarides T. Nucleosome-interacting proteins regulated by DNA and histone methylation. Cell 2010, 143:470-484.
164. Bartels S.J., Spruijt C.G., Brinkman A.B., Jansen P.W., Vermeulen M., Stunnenberg H.G. A SILAC-based screen for methyl-CpG binding proteins identifies RBP-J as a DNA methylation and sequence-specific binding protein. PLoS One 2011, 6:e25884.
165. Hu S., Wan J., Su Y., Song Q., Zeng Y., Nguyen H.N., Shin J., Cox E., Rho H.S., Woodard C., Xia S., Liu S., Lyu H., Ming G.L., Wade H., Song H., Qian J., Zhu H. DNA methylation presents distinct binding sites for human transcription factors. Elife 2013, 2:e00726.
166. Tahiliani M., Koh K.P., Shen Y., Pastor W.A., Bandukwala H., Brudno Y., Agarwal S., Iyer L.M., Liu D.R., Aravind L., Rao A. Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1. Science 2009, 324:930-935.
167. Ito S., D'Alessio A.C., Taranova O.V., Hong K., Sowers L.C., Zhang Y. Role of Tet proteins in 5mC to 5hmC conversion, ES-cell self-renewal and inner cell mass specification. Nature 2010, 466:1129-1133.
168. Kriaucionis S., Heintz N. The nuclear DNA base 5-hydroxymethylcytosine is present in Purkinje neurons and the brain. Science 2009, 324:929-930.
169. Ito S., Shen L., Dai Q., Wu S.C., Collins L.B., Swenberg J.A., He C., Zhang Y. Tet proteins can convert 5-methylcytosine to 5-formylcytosine and 5-carboxylcytosine. Science 2011, 333:1300-1303.
170. He Y.F., Li B.Z., Li Z., Liu P., Wang Y., Tang Q., Ding J., Jia Y., Chen Z., Li L., Sun Y., Li X., Dai Q., Song C.X., Zhang K., He C., Xu G.L. Tet-mediated formation of 5-carboxylcytosine and its excision by TDG in mammalian DNA. Science 2011, 333:1303-1307.
171. Iurlaro M., Ficz G., Oxley D., Raiber E.A., Bachman M., Booth M.J., Andrews S., Balasubramanian S., Reik W. A screen for hydroxymethylcytosine and formylcytosine binding proteins suggests functions in transcription and chromatin regulation. Genome Biol. 2013, 14:R119.
172. Mellen M., Ayata P., Dewell S., Kriaucionis S., Heintz N. MeCP2 binds to 5hmC enriched within active genes and accessible chromatin in the nervous system. Cell 2012, 151:1417-1430.
173. Frauer C., Hoffmann T., Bultmann S., Casa V., Cardoso M.C., Antes I., Leonhardt H. Recognition of 5-hydroxymethylcytosine by the Uhrf1 SRA domain. PLoS One 2011, 6:e21306.
174. Pichler G., Wolf P., Schmidt C.S., Meilinger D., Schneider K., Frauer C., Fellinger K., Rottach A., Leonhardt H. Cooperative DNA and histone binding by Uhrf2 links the two major repressive epigenetic pathways. J. Cell. Biochem. 2011, 112:2585-2593.
175. Zhang J., Gao Q., Li P., Liu X., Jia Y., Wu W., Li J., Dong S., Koseki H., Wong J. S phase-dependent interaction with DNMT1 dictates the role of UHRF1 but not UHRF2 in DNA methylation maintenance. Cell Res. 2011, 21:1723-1739.
176. Kudo S., Nomura Y., Segawa M., Fujita N., Nakao M., Schanen C., Tamura M. Heterogeneity in residual function of MeCP2 carrying missense mutations in the methyl CpG binding domain. J. Med. Genet. 2003, 40:487-493.
177. Bird A., Taggart M., Frommer M., Miller O.J., Macleod D. A fraction of the mouse genome that is derived from islands of nonmethylated, CpG-rich DNA. Cell 1985, 40:91-99.
178. Long H.K., Blackledge N.P., Klose R.J. ZF-CxxC domain-containing proteins, CpG islands and the chromatin connection. Biochem. Soc. Trans. 2013, 41:727-740.
179. Lee J.H., Skalnik D.G. CpG-binding protein (CXXC finger protein 1) is a component of the mammalian Set1 histone H3-Lys4 methyltransferase complex, the analogue of the yeast Set1/COMPASS complex. J. Biol. Chem. 2005, 280:41725-41731.
180. Thomson J.P., Skene P.J., Selfridge J., Clouaire T., Guy J., Webb S., Kerr A.R., Deaton A., Andrews R., James K.D., Turner D.J., Illingworth R., Bird A. CpG islands influence chromatin structure via the CpG-binding protein Cfp1. Nature 2010, 464:1082-1086.
181. Frauer C., Rottach A., Meilinger D., Bultmann S., Fellinger K., Hasenoder S., Wang M., Qin W., Soding J., Spada F., Leonhardt H. Different binding properties and function of CXXC zinc finger domains in Dnmt1 and Tet1. PLoS One 2011, 6:e16627.
182. Xu Y., Wu F., Tan L., Kong L., Xiong L., Deng J., Barbera A.J., Zheng L., Zhang H., Huang S., Min J., Nicholson T., Chen T., Xu G., Shi Y., Zhang K., Shi Y.G. Genome-wide regulation of 5hmC, 5mC, and gene expression by Tet1 hydroxylase in mouse embryonic stem cells. Mol. Cell 2011, 42:451-464.
183. Zhang H., Zhang X., Clark E., Mulcahey M., Huang S., Shi Y.G. TET1 is a DNA-binding protein that modulates DNA methylation and gene transcription via hydroxylation of 5-methylcytosine. Cell Res. 2010, 20:1390-1393.
184. Xu Y., Xu C., Kato A., Tempel W., Abreu J.G., Bian C., Hu Y., Hu D., Zhao B., Cerovina T., Diao J., Wu F., He H.H., Cui Q., Clark E., Ma C., Barbara A., Veenstra G.J., Xu G., Kaiser U.B., Liu X.S., Sugrue S.P., He X., Min J., Kato Y., Shi Y.G. Tet3 CXXC domain and dioxygenase activity cooperatively regulate key genes for Xenopus eye and neural development. Cell 2012, 151:1200-1213.
185. Iyer L.M., Abhiman S., Aravind L. Natural history of eukaryotic DNA methylation systems. Prog. Mol. Biol. Transl. Sci. 2011, 101:25-104.
186. Ko M., An J., Bandukwala H.S., Chavez L., Aijo T., Pastor W.A., Segal M.F., Li H., Koh K.P., Lahdesmaki H., Hogan P.G., Aravind L., Rao A. Modulation of TET2 expression and 5-methylcytosine oxidation by the CXXC domain protein IDAX. Nature 2013, 497:122-126.
187. Blackledge N.P., Zhou J.C., Tolstorukov M.Y., Farcas A.M., Park P.J., Klose R.J. CpG islands recruit a histone H3 lysine 36 demethylase. Mol. Cell 2010, 38:179-190.
188. Ramirez J., Dege C., Kutateladze T.G., Hagman J. MBD2 and multiple domains of CHD4 are required for transcriptional repression by Mi-2/NuRD complexes. Mol. Cell. Biol. 2012, 32:5078-5088.
189. Vermeulen M., Mulder K.W., Denissov S., Pijnappel W.W., van Schaik F.M., Varier R.A., Baltissen M.P., Stunnenberg H.G., Mann M., Timmers H.T. Selective anchoring of TFIID to nucleosomes by trimethylation of histone H3 lysine 4. Cell 2007, 131:58-69.
190. Lauberth S.M., Nakayama T., Wu X., Ferris A.L., Tang Z., Hughes S.H., Roeder R.G. H3K4me3 interactions with TAF3 regulate preinitiation complex assembly and selective gene activation. Cell 2013, 152:1021-1036.
191. Tsukada Y., Fang J., Erdjument-Bromage H., Warren M.E., Borchers C.H., Tempst P., Zhang Y. Histone demethylation by a family of JmjC domain-containing proteins. Nature 2006, 439:811-816.
192. Clouaire T., Webb S., Skene P., Illingworth R., Kerr A., Andrews R., Lee J.H., Skalnik D., Bird A. Cfp1 integrates both CpG content and gene activity for accurate H3K4me3 deposition in embryonic stem cells. Genes Dev. 2012, 26:1714-1728.
193. Smith Z.D., Meissner A. DNA methylation: roles in mammalian development. Nat. Rev. Genet. 2013, 14:204-220.
194. Ziller M.J., Gu H., Muller F., Donaghey J., Tsai L.T., Kohlbacher O., De Jager P.L., Rosen E.D., Bennett D.A., Bernstein B.E., Gnirke A., Meissner A. Charting a dynamic DNA methylation landscape of the human genome. Nature 2013, 500:477-481.
195. Chen T., Hevi S., Gay F., Tsujimoto N., He T., Zhang B., Ueda Y., Li E. Complete inactivation of DNMT1 leads to mitotic catastrophe in human cancer cells. Nat. Genet. 2007, 39:391-396.
196. Jones P.A., Baylin S.B. The epigenomics of cancer. Cell 2007, 128:683-692.
197. Seisenberger S., Andrews S., Krueger F., Arand J., Walter J., Santos F., Popp C., Thienpont B., Dean W., Reik W. The dynamics of genome-wide DNA methylation reprogramming in mouse primordial germ cells. Mol. Cell 2012, 48:849-862.
198. Otani J., Nankumo T., Arita K., Inamoto S., Ariyoshi M., Shirakawa M. Structural basis for recognition of H3K4 methylation status by the DNA methyltransferase 3A ATRX-DNMT3-DNMT3L domain. EMBO Rep. 2009, 10:1235-1241.
199. Ooi S.K., Qiu C., Bernstein E., Li K., Jia D., Yang Z., Erdjument-Bromage H., Tempst P., Lin S.P., Allis C.D., Cheng X., Bestor T.H. DNMT3L connects unmethylated lysine 4 of histone H3 to de novo methylation of DNA. Nature 2007, 448:714-717.
200. Iwase S., Xiang B., Ghosh S., Ren T., Lewis P.W., Cochrane J.C., Allis C.D., Picketts D.J., Patel D.J., Li H., Shi Y. ATRX ADD domain links an atypical histone methylation recognition mechanism to human mental-retardation syndrome. Nat. Struct. Mol. Biol. 2011, 18:769-776.
201. Zhang Y., Jurkowska R., Soeroes S., Rajavelu A., Dhayalan A., Bock I., Rathert P., Brandt O., Reinhardt R., Fischle W., Jeltsch A. Chromatin methylation activity of Dnmt3a and Dnmt3a/3L is guided by interaction of the ADD domain with the histone H3 tail. Nucleic Acids Res. 2010, 38:4246-4253.
202. Ge Y.Z., Pu M.T., Gowher H., Wu H.P., Ding J.P., Jeltsch A., Xu G.L. Chromatin targeting of de novo DNA methyltransferases by the PWWP domain. J. Biol. Chem. 2004, 279:25447-25454.
203. Chen T., Tsujimoto N., Li E. The PWWP domain of Dnmt3a and Dnmt3b is required for directing DNA methylation to the major satellite repeats at pericentric heterochromatin. Mol. Cell. Biol. 2004, 24:9048-9058.
204. Qiu C., Sawada K., Zhang X., Cheng X. The PWWP domain of mammalian DNA methyltransferase Dnmt3b defines a new family of DNA-binding folds. Nat. Struct. Biol. 2002, 9:217-224.
205. Dhayalan A., Rajavelu A., Rathert P., Tamas R., Jurkowska R.Z., Ragozin S., Jeltsch A. The Dnmt3a PWWP domain reads histone 3 lysine 36 trimethylation and guides DNA methylation. J. Biol. Chem. 2010, 285:26114-26120.
206. Jones P.A. Functions of DNA methylation: islands, start sites, gene bodies and beyond. Nat. Rev. Genet. 2012, 13:484-492.
207. Neri F., Krepelova A., Incarnato D., Maldotti M., Parlato C., Galvagni F., Matarese F., Stunnenberg H.G., Oliviero S. Dnmt3L antagonizes DNA methylation at bivalent promoters and favors DNA methylation at gene bodies in ESCs. Cell 2013, 155:121-134.
208. Chuang L.S., Ian H.I., Koh T.W., Ng H.H., Xu G., Li B.F. Human DNA-(cytosine-5) methyltransferase-PCNA complex as a target for p21WAF1. Science 1997, 277:1996-2000.
209. Spada F., Haemmer A., Kuch D., Rothbauer U., Schermelleh L., Kremmer E., Carell T., Langst G., Leonhardt H. DNMT1 but not its interaction with the replication machinery is required for maintenance of DNA methylation in human cells. J. Cell Biol. 2007, 176:565-571.
210. Pradhan M., Esteve P.O., Chin H.G., Samaranayke M., Kim G.D., Pradhan S. CXXC domain of human DNMT1 is essential for enzymatic activity. Biochemistry 2008, 47:10000-10009.
211. Bestor T.H., Ingram V.M. Two DNA methyltransferases from murine erythroleukemia cells: purification, sequence specificity, and mode of interaction with DNA. Proc. Natl. Acad. Sci. U. S. A. 1983, 80:5559-5563.
212. Bashtrykov P., Jankevicius G., Smarandache A., Jurkowska R.Z., Ragozin S., Jeltsch A. Specificity of Dnmt1 for methylation of hemimethylated CpG sites resides in its catalytic domain. Chem. Biol. 2012, 19:572-578.
213. Takeshita K., Suetake I., Yamashita E., Suga M., Narita H., Nakagawa A., Tajima S. Structural insight into maintenance methylation by mouse DNA methyltransferase 1 (Dnmt1). Proc. Natl. Acad. Sci. U. S. A. 2011, 108:9055-9059.
214. Syeda F., Fagan R.L., Wean M., Avvakumov G.V., Walker J.R., Xue S., Dhe-Paganon S., Brenner C. The replication focus targeting sequence (RFTS) domain is a DNA-competitive inhibitor of Dnmt1. J. Biol. Chem. 2011, 286:15344-15351.
215. Dikic I., Wakatsuki S., Walters K.J. Ubiquitin-binding domains - from structures to functions. Nat. Rev. Mol. Cell Biol. 2009, 10:659-671.
216. Nakamura T., Liu Y.J., Nakashima H., Umehara H., Inoue K., Matoba S., Tachibana M., Ogura A., Shinkai Y., Nakano T. PGC7 binds histone H3K9me2 to protect against conversion of 5mC to 5hmC in early embryos. Nature 2012, 486:415-419.
217. Nakamura T., Arai Y., Umehara H., Masuhara M., Kimura T., Taniguchi H., Sekimoto T., Ikawa M., Yoneda Y., Okabe M., Tanaka S., Shiota K., Nakano T. PGC7/Stella protects against DNA demethylation in early embryogenesis. Nat. Cell Biol. 2007, 9:64-71.
218. Seisenberger S., Peat J.R., Reik W. Conceptual links between DNA methylation reprogramming in the early embryo and primordial germ cells. Curr. Opin. Cell Biol. 2013, 25:281-288.
219. Lowary P.T., Widom J. New DNA sequence rules for high affinity binding to histone octamer and sequence-directed nucleosome positioning. J. Mol. Biol. 1998, 276:19-42.
220. Clouaire T., de Las Heras J.I., Merusi C., Stancheva I. Recruitment of MBD1 to target genes requires sequence-specific interaction of the MBD domain with methylated DNA. Nucleic Acids Res. 2010, 38:4620-4634.
221. Klose R.J., Sarraf S.A., Schmiedeberg L., McDermott S.M., Stancheva I., Bird A.P. DNA binding selectivity of MeCP2 due to a requirement for A/T sequences adjacent to methyl-CpG. Mol. Cell 2005, 19:667-678.
222. Ramsahoye B.H., Biniszkiewicz D., Lyko F., Clark V., Bird A.P., Jaenisch R. Non-CpG methylation is prevalent in embryonic stem cells and may be mediated by DNA methyltransferase 3a. Proc. Natl. Acad. Sci. U. S. A. 2000, 97:5237-5242.
223. Han J., Zhang H., Wang Z., Zhou H., Zhang Z. A Cul4 E3 ubiquitin ligase regulates histone hand-off during nucleosome assembly. Cell 2013, 155:817-829.
224. Byrum S.D., Raman A., Taverna S.D., Tackett A.J. ChAP-MS: a method for identification of proteins and histone posttranslational modifications at a single genomic locus. Cell Rep. 2012, 2:198-205.
225. Byrum S.D., Taverna S.D., Tackett A.J. Purification of a specific native genomic locus for proteomic analysis. Nucleic Acids Res. 2013, 41:e195.
226. Leroy G., Chepelev I., Dimaggio P.A., Blanco M.A., Zee B.M., Zhao K., Garcia B.A. Proteogenomic characterization and mapping of nucleosomes decoded by Brd and HP1 proteins. Genome Biol. 2012, 13:R68.
227. Wang C.I., Alekseyenko A.A., LeRoy G., Elia A.E., Gorchakov A.A., Britton L.M., Elledge S.J., Kharchenko P.V., Garcia B.A., Kuroda M.I. Chromatin proteins captured by ChIP-mass spectrometry are linked to dosage compensation in Drosophila. Nat. Struct. Mol. Biol. 2013, 20:202-209.
228. Gaj T., Gersbach C.A., Barbas C.F. ZFN, TALEN, and CRISPR/Cas-based methods for genome engineering. Trends Biotechnol. 2013, 31:397-405.
229. Gilbert L.A., Larson M.H., Morsut L., Liu Z., Brar G.A., Torres S.E., Stern-Ginossar N., Brandman O., Whitehead E.H., Doudna J.A., Lim W.A., Weissman J.S., Qi L.S. CRISPR-mediated modular RNA-guided regulation of transcription in eukaryotes. Cell 2013, 154:442-451.
230. Maeder M.L., Angstman J.F., Richardson M.E., Linder S.J., Cascio V.M., Tsai S.Q., Ho Q.H., Sander J.D., Reyon D., Bernstein B.E., Costello J.F., Wilkinson M.F., Joung J.K. Targeted DNA demethylation and activation of endogenous genes using programmable TALE-TET1 fusion proteins. Nat. Biotechnol. 2013, 31:1137-1142.
231. Mendenhall E.M., Williamson K.E., Reyon D., Zou J.Y., Ram O., Joung J.K., Bernstein B.E. Locus-specific editing of histone modifications at endogenous enhancers. Nat. Biotechnol. 2013, 31:1133-1136.
232. Konermann S., Brigham M.D., Trevino A.E., Hsu P.D., Heidenreich M., Cong L., Platt R.J., Scott D.A., Church G.M., Zhang F. Optical control of mammalian endogenous transcription and epigenetic states. Nature 2013, 500:472-476.